Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3355 |
|
| Actual shortage: | 217 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
61 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-VERAP TABLET 120MG | 120MG | TABLET | Resolved | 2018-03-13 | 2018-07-12 | 42714 |
| APO-VERAP TABLET 120MG | 120MG | TABLET | Resolved | 2024-09-27 | 2024-11-15 | 238832 |
| APO-VORICONAZOLE | 200MG | TABLET | Resolved | 2017-03-10 | 2017-03-15 | 252 |
| APO-VORICONAZOLE | 50MG | TABLET | Resolved | 2017-06-06 | 2017-08-15 | 12088 |
| APO-VORICONAZOLE | 200MG | TABLET | Resolved | 2017-06-27 | 2017-08-15 | 14073 |
| APO-VORICONAZOLE | 200MG | TABLET | Resolved | 2018-07-11 | 2018-09-12 | 55293 |
| APO-VORICONAZOLE | 50MG | TABLET | Resolved | 2018-07-11 | 2018-09-12 | 55296 |
| APO-WARFARIN | 4MG | TABLET | Resolved | 2018-05-23 | 2018-07-03 | 50162 |
| APO-WARFARIN | 4MG | TABLET | Resolved | 2017-03-12 | 2017-06-08 | 695 |
| APO-WARFARIN | 1MG | TABLET | Resolved | 2023-11-17 | 2023-12-22 | 210698 |
| APO-WARFARIN | 2.5MG | TABLET | Actual shortage | 2024-05-31 | 2024-10-24 | 229419 |
| APO-WARFARIN | 1MG | TABLET | Resolved | 2024-06-13 | 2024-08-16 | 230483 |
| APO-WARFARIN | 1MG | TABLET | Resolved | 2024-04-05 | 2024-05-15 | 224589 |
| APO-WARFARIN | 1MG | TABLET | Resolved | 2024-04-19 | 2024-05-15 | 225782 |
| APO-WARFARIN | 2.5MG | TABLET | Resolved | 2020-01-08 | 2020-06-08 | 102666 |
| APO-WARFARIN | 2.5MG | TABLET | Resolved | 2020-01-08 | 2020-06-08 | 102671 |
| APO-WARFARIN | 5MG | TABLET | Resolved | 2020-04-13 | 2020-05-28 | 111966 |
| APO-WARFARIN | 1MG | TABLET | Resolved | 2020-04-15 | 2020-05-11 | 112208 |
| APO-WARFARIN | 10MG | TABLET | Resolved | 2020-05-13 | 2020-06-22 | 114970 |
| APO-WARFARIN | 2MG | TABLET | Resolved | 2020-05-13 | 2020-07-28 | 114975 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FENTANYL MATRIX | 100MCG | PATCH | Discontinued | 2018-02-23 | 2018-12-28 | 40741 |
| APO-FENTANYL MATRIX | 25MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60489 |
| APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
| APO-FENTANYL MATRIX | 75MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60497 |
| APO-FLUNISOLIDE NASAL SPRAY | 0.25MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40965 |
| APO-FLUVOXAMINE | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4713 |
| APO-FLUVOXAMINE | 50MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4716 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2019-01-02 | 2019-01-02 | 70815 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2018-02-26 | 2018-02-26 | 40997 |
| APO-GEMFIBROZIL | 600MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4927 |
| APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
| APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 | ||
| APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
| APO-HALOPERIDOL TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1084 |
| APO-HALOPERIDOL TAB 5MG | 5MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1087 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROMORPHONE CR | 6MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110959 |